Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease
about
Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's diseaseHeart failure and Alzheimer's diseaseRole of redox signaling in neuroinflammation and neurodegenerative diseasesSpreading of pathology in neurodegenerative diseases: a focus on human studiesStatins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretionGain in brain immunity in the oldest-old differentiates cognitively normal from demented individualsAlzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brainIncreased matrix metalloproteinase 9 activity in mild cognitive impairment.A rat model of mild cognitive impairment associated with vascular factor.Serum levels of S100B and NSE proteins in Alzheimer's disease patientsRegional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysisIncrease of cytosolic phospholipase A2 as hydrolytic enzyme of phospholipids and autism cognitive, social and sensory dysfunction severity.WNT5A signaling contributes to Aβ-induced neuroinflammation and neurotoxicity.CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP+PS1 bigenic miceAge-dependent therapeutic effect of memantine in a mouse model of juvenile Batten diseaseT cells promote the regeneration of neural precursor cells in the hippocampus of Alzheimer's disease mice.Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expressionInverse correlation between Alzheimer's disease and cancer: implication for a strong impact of regenerative propensity on neurodegeneration?WNT signaling in activated microglia is proinflammatory.Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse modelNeurobiology of vascular dementia.Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten diseaseThe role of astroglia in neuroprotectionChronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathyMultiple cytokines are involved in the early events leading to the Alzheimer's disease pathologyAstrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD).The neuroprotective effects of milk fat globule-EGF factor 8 against oligomeric amyloid β toxicity.Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicityExpression of scavenger receptor A on antigen presenting cells is important for CD4+ T-cells proliferation in EAE mouse model.Amyloid fibrils trigger the release of neutrophil extracellular traps (NETs), causing fibril fragmentation by NET-associated elastase.Morphological and genetic activation of microglia after diffuse traumatic brain injury in the rat.Enhanced expression of glia maturation factor correlates with glial activation in the brain of triple transgenic Alzheimer's disease mice.Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease.Glia maturation factor induces interleukin-33 release from astrocytes: implications for neurodegenerative diseases.Gene therapy for misfolding protein diseases of the central nervous system.Cudrania cochinchinensis attenuates amyloid β protein-mediated microglial activation and promotes glia-related clearance of amyloid β protein.PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's diseaseGlial glucocorticoid receptors in aged Fisher 344 (F344) and F344/Brown Norway rats.Astrocyte-neuron interactions in neurological disorders.Amyloid β peptide-mediated neurotoxicity is attenuated by the proliferating microglia more potently than by the quiescent phenotype.
P2860
Q26766462-66235CB6-B6C2-4CA7-88EF-7304EF079524Q26852526-9220E6A9-6ED2-42B8-B083-6AC30503A9FCQ27012569-E9E24823-28F5-4749-A001-3148EB633E3AQ28082279-73F057E6-03F5-4AF1-AE51-11710242BC4FQ28294279-E8306701-73CB-4618-A05C-A9BD889E112BQ33513475-DBFCE71A-3F60-44E9-8832-7DF8233A7295Q33589491-A66DBD50-34EE-4966-8580-86C5ECAD183EQ33605481-688EFA7B-63B7-47B5-B2DB-A9F8DC6D5634Q33643641-90B5813C-CF30-454E-9212-5B2E0089A352Q33705590-F75B707D-4FB9-4FE4-A628-D1AAD9EF91FCQ33797852-9A2582D5-6388-497F-A9E3-0CE359F5FCB0Q33916678-84492159-613C-4BD8-AACE-23A13A9B8174Q33999052-3DDEC31D-0F5A-4B32-B8FA-AC47B846829BQ34017180-3589FB95-461A-45B7-B44F-B57A98380725Q34280201-502C7863-4758-4473-A583-30509B5D6CBFQ34319616-CDEA83AA-9BB6-45F0-BD35-81AC50941F75Q34503290-55D517E1-0215-47CD-9093-2BEE7B01024EQ34515438-01D24E3E-1AE8-43D0-80FC-74C561373367Q34722036-00F2505E-2E80-4068-8907-F08C5CEADD9FQ35105958-2641E7AC-DF5C-4C90-A9B3-0866AFB8064DQ35176496-BC24E57B-84F0-456B-9CFD-566DB210493AQ35216601-AFC62B21-42BF-41AC-8585-8DD85E53AE48Q35237112-42A0C119-89C7-43C3-A074-0EE698FD9990Q35590867-84183FD6-73CB-4D8E-86AE-F11EB052E0E5Q35954373-CBE81B37-3A9E-4769-BD83-7C78C43707EFQ36033271-15544765-A20E-4D1C-BF0A-58C275F1895FQ36162609-2B2291B5-2761-4B65-B556-6B3D594B0A80Q36174802-E74ECDB3-9E62-413B-B2F5-D6AEFC0BC7F5Q36303893-D270E3A5-50EF-43B3-A9E2-AC4C11651DD0Q36347798-FA442631-1D65-4D51-AB58-568E50A46583Q36372703-7065A5BF-527C-4AFA-8566-30D64936DF21Q36481121-EDFADE0A-8C09-4F77-9F18-AE8193B1DD6FQ36600561-5D302C11-E003-422E-95FF-63D8B839D5C6Q36863846-B7FDC104-8C75-4BF1-881E-A67F233BE20CQ36983203-7D3E58AE-426D-4041-B1E6-1CB9EE49DA90Q37113047-2725800F-F38F-404B-8BD3-08CB1CA299EBQ37310632-9014E937-E494-4548-BD03-3A2CC1C63626Q37334682-61F843C7-E76C-4C6F-A55B-FA89D68274B1Q37361072-D880BE8A-75DB-453A-8AD0-F09455C45605Q37410114-D242CC70-2A69-447A-8A42-7E13AE94CBE0
P2860
Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Neuroprotective and neurotoxic ...... genesis of Alzheimer's disease
@ast
Neuroprotective and neurotoxic ...... genesis of Alzheimer's disease
@en
type
label
Neuroprotective and neurotoxic ...... genesis of Alzheimer's disease
@ast
Neuroprotective and neurotoxic ...... genesis of Alzheimer's disease
@en
prefLabel
Neuroprotective and neurotoxic ...... genesis of Alzheimer's disease
@ast
Neuroprotective and neurotoxic ...... genesis of Alzheimer's disease
@en
P2093
P2860
P921
P3181
P1476
Neuroprotective and neurotoxic ...... genesis of Alzheimer's disease
@en
P2093
D. Farfara
D. Frenkel
V. Lifshitz
P2860
P304
P3181
P356
10.1111/J.1582-4934.2008.00314.X
P577
2008-06-01T00:00:00Z